BWAY

BrainsWay Ltd. American Depositary Shares (BWAY)

About BrainsWay Ltd. American Depositary Shares (BWAY)

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Details

Daily high

$11.19

Daily low

$10.66

Price at open

$10.93

52 Week High

$11.25

52 Week Low

$4.61

Market cap

201.1M

Dividend yield

0.00%

Volume

30,015

Avg. volume

55,358

P/E ratio

118.78

BrainsWay Ltd. American Depositary Shares News